(GEN:Toronto Stock Exchange)
Transactions by GENENEWS LTD (GEN) in the last 6 months
GeneNews Limited (TSX:GEN) announced a non-brokered private placement of 3,956,249 units at a price of CAD 0.32 per unit for gross proceeds of CAD 1,265,999.68 on August 19, 2015. Each unit consists of one common share and one share purchase warrant. Each warrant entitles the holder to purchase one common share of the company at an exercise price of CAD 0.50 per share and exercisable until September 15, 2017. Rory Riggs has subscribed 1,562,500 units in the transaction. ...
GeneNes Limited (TSX:GEN) announced a non-brokered private placement of 8,668,240 units at a price of CAD 0.35 per unit for gross proceeds of CAD 3,033,884 on July 15, 2015. Each unit is comprised of one common share and one-half warrant. Each whole warrant entitles the holder to purchase one common share at an exercise price of CAD 0.50 for a period of 1 year following the date of issue, subject to customary adjustment provisions. Certain insiders of
the company have ...
Cobalt Healthcare Consultants, Inc. and GeneNews Limited (TSX:GEN) acquired 33.33% stake in Innovative Diagnostic Laboratory, LLP (IDL) from Health Diagnostic Laboratory, Inc. (HDL) for $4 million in cash and promissory notes on May 15, 2015. The purchase price payable by each of GeneNews and Cobalt will be satisfied in part with each company issuing a one-year secured promissory note in the principal amount of $1 million and the balance of the purchase price to be paid ...
|No competitor information is available for GEN.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|